TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.5 BREAKDOWN OF PRIMARY RESPONDENTS
3.6 FORECASTING TECHNIQUES
3.7 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.7.1 BOTTOM-UP APPROACH
3.7.2 TOP-DOWN APPROACH
3.8 DATA TRIANGULATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF SLEEP BRUXISM
4.2.2 GROWING CHILD POPULATION
4.2.3 RISING PREVALENCE OF OBSTRUCTIVE SLEEP APNEA
4.2.4 LIFESTYLE CHANGES
4.3 RESTRAINT
4.3.1 LIMITED AVAILABILITY OF TREATMENT OPTIONS
4.4 OPPORTUNITY
4.4.1 UNTAPPED MARKETS IN ASIA-PACIFIC
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D AND DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES REVIEW
5.2 FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF BUYERS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19
5.3.1 IMPACT ON POPULATION HEALTH
5.3.2 IMPACT ON DEMAND
6 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE
6.1 OVERVIEW
6.2 PRIMARY BRUXISM
6.3 SECONDARY BRUXISM
7 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE
7.1 OVERVIEW
7.2 OBSTRUCTIVE SLEEP APNEA
7.3 GASTROESOPHAGEAL REFLUX DISEASE
7.4 MALOCCLUSION
7.5 SLEEP PARALYSIS
8 GLOBAL SLEEPING BRUXISM TREATMENT MARKET BY TREATMENT
8.1 OVERVIEW
8.2 DENTAL APPROACHES
8.2.1 MOUTH GUARD
8.2.2 NTI-TSS DEVICE
8.3 MEDICATION
8.3.1 MUSCLE RELAXANTS
8.3.2 Botulinum Toxin Type A INJECTIONS
8.3.3 ANTI-ANXIETY DRUGS
9 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE
9.1 OVERVIEW
9.2 PAEDIATRIC
9.3 ADULT
9.3.1 MALE
9.3.2 FEMALE
10 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS
10.3 DENTAL CLINICS
11 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY REGION
11.1 INTRODUCTION
11.2 AMERICAS
11.2.1 NORTH AMERICA
11.2.1.1 US
11.2.1.2 CANADA
11.2.2 LATIN AMERICA
11.3 EUROPE
11.3.1 WESTERN EUROPE
11.3.1.1 GERMANY
11.3.1.2 FRANCE
11.3.1.3 UK
11.3.1.4 SCANDINAVIA
11.3.1.4.1 KINGDOM OF DENMARK
11.3.1.4.2 NORWAY
11.3.1.4.3 SWEDEN
11.3.1.4.4 FINLAND
11.3.1.4.5 ICELAND
11.3.1.5 BENELUX UNION
11.3.1.5.1 BELGIUM
11.3.1.5.2 NETHERLANDS
11.3.1.5.3 LUXEMBOURG
11.3.1.6 ITALY
11.3.1.7 SPAIN
11.3.1.8 SWITZERLAND
11.3.1.9 REST OF WESTERN EUROPE
11.3.2 EASTERN EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 INDIA
11.4.3 JAPAN
11.4.4 SOUTH KOREA
11.4.5 REST OF ASIA PACIFIC
11.5 MIDDLE EAST & AFRICA
11.5.1 MIDDLE EAST
11.5.2 AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET
12.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET
12.5 KEY DEVELOPMENT ANALYSIS
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.6.1 PRODUCT LAUNCH
12.6.2 ACQUISITION
12.6.3 PARTNERSHIP
12.7 MAJOR PLAYERS FINANCIAL MATRIX
12.7.1 SALES & OPERATING INCOME MARGIN (USD MILLION), 2020
12.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020
13 COMPANY PROFILES
13.1 IVOCLAR VIVADENT AG
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS/SERVICES OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 IPSEN S.A.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS/SERVICES OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 MERZ PHARMA GMBH & CO. KGAA
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS/SERVICES OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 SWOT ANALYSIS
13.3.6 KEY STRATEGIES
13.4 CARESTREAM DENTAL
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS/SERVICES OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 SWOT ANALYSIS
13.4.6 KEY STRATEGIES
13.5 AKERVALL TECHNOLOGIES INC.
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS/SERVICES OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 PLANMECA OY
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS/SERVICES OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 RANDMARK DENTAL PRODUCTS, LLC
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCTS/SERVICES OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 SWOT ANALYSIS
13.7.6 KEY STRATEGIES
13.8 S4S (UK) LIMITED
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL OVERVIEW
13.8.3 PRODUCTS/SERVICES OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 SWOT ANALYSIS
13.8.6 KEY STRATEGIES
13.9 PATTERSON DENTAL SUPPLY, INC.
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS/SERVICES OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 HENRY SCHEIN, INC.
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL OVERVIEW
13.10.3 PRODUCTS/SERVICES OFFERED
13.10.4 KEY DEVELOPMENTS
13.10.5 SWOT ANALYSIS
13.10.6 KEY STRATEGIES
13.11 PFIZER, INC.
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL OVERVIEW
13.11.3 PRODUCTS/SERVICES OFFERED
13.11.4 KEY DEVELOPMENTS
13.11.5 SWOT ANALYSIS
13.11.6 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 3 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR PRIMARY BRUXISM, BY REGION, 2018–2027 (USD MILLION)
TABLE 4 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR SECONDARY BRUXISM, BY REGION, 2018–2027 (USD MILLION)
TABLE 5 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 6 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET FOR OBSTRUCTIVE SLEEP APNEA, BY REGION, 2018–2027 (USD MILLION)
TABLE 7 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018–2027 (USD MILLION)
TABLE 8 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MALOCCLUSION, BY REGION, 2018–2027 (USD MILLION)
TABLE 9 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR SLEEP PARALYSIS, BY REGION, 2018–2027 (USD MILLION)
TABLE 10 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 11 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY REGION, 2018–2027 (USD MILLION)
TABLE 12 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TREATMENT TYPE 2018–2027 (USD MILLION)
TABLE 13 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MOUTH GUARD, BY REGION, 2018–2027 (USD MILLION)
TABLE 14 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR NTI-TSS DEVICE, BY REGION, 2018–2027 (USD MILLION)
TABLE 15 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY REGION, 2018–2027 (USD MILLION)
TABLE 16 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TREATMENT TYPE 2018–2027 (USD MILLION)
TABLE 17 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MUSCLE RELAXANTS, BY REGION, 2018–2027 (USD MILLION)
TABLE 18 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR BINJECTIONS, BY REGION, 2018–2027 (USD MILLION)
TABLE 19 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR ANTI-ANXIETY DRUGS, BY REGION, 2018–2027 (USD MILLION)
TABLE 20 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 21 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR PAEDIATRIC, BY REGION 2018-2027 (USD MILLION)
TABLE 22 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY REGION 2018-2027 (USD MILLION)
TABLE 23 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, FOR ADULT, 2018-2027 (USD MILLION)
TABLE 24 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, FOR MALE, BY REGION 2018-2027 (USD MILLION)
TABLE 25 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, FOR FEMALE, BY REGION 2018-2027 (USD MILLION)
TABLE 26 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 27 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 30 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 31 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 32 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 33 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 34 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 35 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 36 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 37 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 38 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 39 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 40 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 41 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 42 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 43 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 44 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 45 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 46 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 47 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 48 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 49 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 50 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 52 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 53 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 54 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 55 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 56 US SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 57 US SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 58 US SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 59 US SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 60 US SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 61 US SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 62 US SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 63 US SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 64 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 65 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 66 CANADA SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 67 CANADA SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 68 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 69 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 70 CANADA SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 71 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 72 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 73 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 74 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 75 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 76 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 77 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 78 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 79 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 80 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 81 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 82 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 83 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 84 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 85 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 86 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 87 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 88 EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 89 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 90 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 91 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 92 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 93 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 94 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 95 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 96 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 97 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 98 GERMANY: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 99 GERMANY: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 100 GERMANY: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 101 GERMANY: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 102 GERMANY: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 103 GERMANY: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 104 GERMANY: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 105 GERMANY: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 106 FRANCE: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 107 FRANCE: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 108 FRANCE: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 109 FRANCE: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 110 FRANCE: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 111 FRANCE: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 112 FRANCE: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 113 FRANCE: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 114 UK: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 115 UK: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 116 UK: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 117 UK: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 118 UK: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 119 UK: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 120 UK: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 121 UK: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 122 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 123 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 124 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 125 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 126 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 127 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 128 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 129 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 130 SCANDINAVIA: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 131 KINGDOMS OF DENMARK: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 132 KINGDOMS OF DENMARK: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 133 KINGDOMS OF DENMARK: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 134 KINGDOMS OF DENMARK: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 135 KINGDOMS OF DENMARK: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 136 KINGDOMS OF DENMARK: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 137 KINGDOMS OF DENMARK: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 138 KINGDOMS OF DENMARK: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 139 NORWAY: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 140 NORWAY: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 141 NORWAY: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 142 NORWAY: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 143 NORWAY: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 144 NORWAY: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 145 NORWAY: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 146 NORWAY: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 147 SWEDEN: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 148 SWEDEN: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 149 SWEDEN: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 150 SWEDEN: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 151 SWEDEN: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 152 SWEDEN: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 153 SWEDEN: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 154 SWEDEN: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 155 FINLAND: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 156 FINLAND: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 157 FINLAND: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 158 FINLAND: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 159 FINLAND: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 160 FINLAND: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 161 FINLAND: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 162 FINLAND: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 163 ICE LAND: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 164 ICE LAND: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 165 ICE LAND: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 166 ICE LAND: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 167 ICE LAND: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 168 ICE LAND: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 169 ICE LAND: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 170 ICE LAND: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 171 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 172 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 173 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 174 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 175 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 176 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 177 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 178 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 179 BENELUX UNION: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 180 BELGIUM: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 181 BELGIUM: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 182 BELGIUM: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 183 BELGIUM: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 184 BELGIUM: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 185 BELGIUM: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 186 BELGIUM: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 187 BELGIUM: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 188 NETHERLANDS: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 189 NETHERLANDS: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 190 NETHERLANDS: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 191 NETHERLANDS: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 192 NETHERLANDS: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 193 NETHERLANDS: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 194 NETHERLANDS: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 195 NETHERLANDS: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 196 LUXEMBOURG: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 197 LUXEMBOURG: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 198 LUXEMBOURG: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 199 LUXEMBOURG: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 200 LUXEMBOURG: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 201 LUXEMBOURG: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 202 LUXEMBOURG: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 203 LUXEMBOURG: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 204 ITALY: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 205 ITALY: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 206 ITALY: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 207 ITALY: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 208 ITALY: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 209 ITALY: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 210 ITALY: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 211 ITALY: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 212 SPAIN: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 213 SPAIN: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 214 SPAIN: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 215 SPAIN: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 216 SPAIN: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 217 SPAIN: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 218 SPAIN: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 219 SPAIN: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 220 SWITZERLAND: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 221 SWITZERLAND: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 222 SWITZERLAND: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 223 SWITZERLAND: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 224 SWITZERLAND: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 225 SWITZERLAND: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 226 SWITZERLAND: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 227 SWITZERLAND: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 228 REST OF WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 229 REST OF WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 230 REST OF WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 231 REST OF WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 232 REST OF WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 233 REST OF WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 234 REST OF WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 235 REST OF WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 236 EASTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 237 EASTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018–2027 (USD MILLION)
TABLE 238 EASTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY DENTAL APPROACHES, 2018–2027 (USD MILLION)
TABLE 239 EASTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY MEDICATION, 2018–2027 (USD MILLION)
TABLE 240 EASTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 241 EASTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018–2027 (USD MILLION)
TABLE 242 EASTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, 2018–2027 (USD MILLION)
TABLE 243 EASTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 244 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 245 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 246 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 247 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL APPROACHES, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 248 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 249 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 250 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 251 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET FOR ADULT, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 252 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET FOR ADULT, BY END USER 2018-2027 (USD MILLION)
TABLE 253 CHINA: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 254 CHINA: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 255 CHINA: SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL APPROACHES, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 256 CHINA: SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 257 CHINA: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 258 CHINA: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 259 CHINA: SLEEPING BRUXISM TREATMENT MARKET FOR ADULT, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 260 CHINA: SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 261 INDIA: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 262 INDIA: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 263 INDIA: SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL APPROACHES, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 264 INDIA: SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 265 INDIA: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 266 INDIA: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 267 INDIA: SLEEPING BRUXISM TREATMENT MARKET FOR ADULT, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 268 INDIA: SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 269 JAPAN: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 270 JAPAN: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 271 JAPAN: SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL APPROACHES, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 272 JAPAN: SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 273 JAPAN: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 274 JAPAN: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 275 JAPAN: SLEEPING BRUXISM TREATMENT MARKET FOR ADULT, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 276 JAPAN: SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 277 SOUTH KOREA: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 278 SOUTH KOREA: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 279 SOUTH KOREA: SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL APPROACHES, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 280 SOUTH KOREA: SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 281 SOUTH KOREA: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 282 SOUTH KOREA: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 283 SOUTH KOREA: SLEEPING BRUXISM TREATMENT MARKET FOR ADULT, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 284 SOUTH KOREA: SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 285 REST OF ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 286 REST OF ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 287 REST OF ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL APPROACHES, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 288 REST OF ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 289 REST OF ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 290 REST OF ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 291 REST OF ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET FOR ADULT, BY PATIENT TYPE 2018-2027 (USD MILLION)
TABLE 292 REST OF ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 293 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 294 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 295 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 296 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 297 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 298 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 299 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 300 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 301 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 302 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 303 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 304 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 305 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 306 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 307 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 308 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 309 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 310 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 311 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 312 AFRICA SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 313 AFRICA SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 314 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 315 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 316 AFRICA SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 317 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 318 MAJOR PLAYERS IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET
TABLE 319 MOST ACTIVE PLAYERS IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET
TABLE 320 PRODUCT LAUNCH
TABLE 321 ACQUISITION
TABLE 322 PARTNERSHIP
TABLE 323 IVOCLAR VIVADENT AG: PRODUCTS/SERVICES OFFERED
TABLE 324 IVOCLAR VIVADENT AG: KEY DEVELOPMENTS
TABLE 325 IPSEN S.A.: PRODUCTS/SERVICES OFFERED
TABLE 326 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS/SERVICES OFFERED
TABLE 327 CARESTREAM DENTAL: PRODUCTS/SERVICES OFFERED
TABLE 328 CARESTREAM DENTAL: KEY DEVELOPMENTS
TABLE 329 AKERVALL TECHNOLOGIES INC.: PRODUCTS/SERVICES OFFERED
TABLE 330 PLANMECA OY: PRODUCTS/SERVICES OFFERED
TABLE 331 RANDMARK DENTAL PRODUCTS, LLC: PRODUCTS/SERVICES OFFERED
TABLE 332 S4S (UK) LIMITED: PRODUCTS/SERVICES OFFERED
TABLE 333 PATTERSON DENTAL SUPPLY, INC.: PRODUCTS/SERVICES OFFERED
TABLE 334 HENRY SCHEIN, INC.: PRODUCTS/SERVICES OFFERED
TABLE 335 HENRY SCHEIN, INC.: KEY DEVELOPMENTS
TABLE 336 PFIZER, INC: PRODUCTS/SERVICES OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL SLEEPING BRUXISM TREATMENT MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: GLOBAL SLEEPING BRUXISM TREATMENT MARKET
FIGURE 4 DRIVERS: IMPACT ANALYSIS
FIGURE 5 RESTRAINT: IMPACT ANALYSIS
FIGURE 6 VALUE CHAIN: GLOBAL SLEEPING BRUXISM TREATMENT MARKET
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL SLEEPING BRUXISM TREATMENT MARKET
FIGURE 8 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2020 & 2027 (USD MILLION)
FIGURE 9 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2020 & 2027 (USD MILLION)
FIGURE 10 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2020 & 2027 (USD MILLION)
FIGURE 11 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2020
FIGURE 12 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2020 & 2027
FIGURE 13 GLOBAL: EMERGENCY MEDICAL SERVICES MARKET, BY REGION 2020 & 2027 (USD MILLION)
FIGURE 14 GLOBAL SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2020 (%)
FIGURE 15 AMERICAS SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2020 (%)
FIGURE 16 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2020 (%)
FIGURE 17 EUROPE: SLEEPING BRUXISM TREATMENT MARKET SHARE (%), BY REGION, 2020
FIGURE 18 WESTERN EUROPE: SLEEPING BRUXISM TREATMENT MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 19 ASIA PACIFIC: SLEEPING BRUXISM TREATMENT MARKET SHARE (%), BY COUNTRY 2020
FIGURE 20 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET SHARE (%), BY REGION, 2020
FIGURE 21 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET
FIGURE 23 GLOBAL SLEEPING BRUXISM TREATMENT MARKET: COMPETITIVE LANDSCAPE
FIGURE 24 SALES & OPERATING INCOME MARGIN 2020
FIGURE 25 RESEARCH & DEVELOPMENT EXPENDITURE 2020
FIGURE 26 IVOCLAR VIVADENT AG: SWOT ANALYSIS
FIGURE 27 IPSEN S.A.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 IPSEN S.A.: SWOT ANALYSIS
FIGURE 29 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS
FIGURE 30 CARESTREAM DENTAL: SWOT ANALYSIS
FIGURE 31 AKERVALL TECHNOLOGIES INC.: SWOT ANALYSIS
FIGURE 32 PLANMECA OY: SWOT ANALYSIS
FIGURE 33 RANDMARK DENTAL PRODUCTS, LLC: SWOT ANALYSIS
FIGURE 34 S4S (UK) LIMITED: SWOT ANALYSIS
FIGURE 35 PATTERSON DENTAL SUPPLY, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 PATTERSON DENTAL SUPPLY, INC.: SWOT ANALYSIS
FIGURE 37 HENRY SCHEIN, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 HENRY SCHEIN, INC.: SWOT ANALYSIS
FIGURE 39 PFIZER, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 PFIZER, INC: SWOT ANALYSIS
